abstract |
The present invention provides methods and materials for reducing aggregation of A ?. For example, methods and materials relating to the use of BRI polypeptides (e.g., BRI2 polypeptides) and BRI polypeptide fragments (e.g., BRI23 polypeptide) for reducing aggregation of Aβ in mammals are described. |